Cancer Research

#Avacta #Cancer research #CAR-T #Cell therapy #Immunotherapy #Oncology #Precision medicine #T cell activation #Therapeutic targets

Precision cancer therapies: Where are we?

DDW’s Diana Spencer reports on the recent Avacta Therapeutics Science Day, which explored the latest exciting developments in precision and targeted treatments for cancer and asked what advances the future might bring. The Avacta Therapeutics Science Day brought together senior company scientists and international oncology experts to provide an overview… Read More

#Cancer Research #Exclusive Content

Research in genetics laboratory
#Cancer research #Epigenetics #Gene expression #Genetics / genomics #Oncology #The Institute of Cancer Research

Epigenetics discovery could lead to new class of cancer drugs

A new paper has solved the 20-year mystery of how epigenetic modifications act as traffic lights to control gene expression and could ultimately speed up the development of a new class of epigenetic cancer drugs.  Epigenetics is still largely unexplored and referred to as the ‘dark matter’… Read More

#Cancer Research #Editor's Choice #News

Prostate cancer cells
#Cancer research #Genetics / genomics #Janssen #Oncology #Phase III trial #Prostate cancer

PARP inhibitor slows progression in HRR-positive prostate cancer

Janssen has revealed updated results from the Phase III MAGNITUDE study, which show that a combination therapy including niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, slowed prostate cancer progression.  The drug was investigated in combination with abiraterone acetate plus prednisone (AAP) in patients with metastatic castration-resistant prostate… Read More

#Cancer Research #News

Macrophage
#Cancer research #Immunology #Macomics #Mass spectrometry / NMR #Oncology #Transcriptomics #Tumour biology #Tumour microenvironment (TME)

Scottish company will target macrophages to treat cancer

Newly published discoveries have revealed possibilities for the treatment of cancer by targeting tumour-associated macrophages (TAMs) in the tumour microenvironment (TME).  The founding scientists behind Edinburgh-based Macomics, Dr Luca Cassetta and Professor Jeff Pollard, detail the seminal discoveries in macrophage biology over the past 50 years in… Read More

#Cancer Research #News

Testing visual acuity
#Aura Biosciences #Cancer research #Melanoma #Oncology #Ophthalmology #Phase II trial

Choroidal melanoma drug preserved vision in Phase II study

Aura Biosciences has announced positive interim Phase II safety and efficacy data for belzupacap sarotalocan (bel-sar) as a first-line treatment for patients with early-stage choroidal melanoma with suprachoroidal administration.  The results showed a statistically significant reduction in tumour growth rate compared to each patient’s documented growth rate… Read More

#Cancer Research #News

Big genomic data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Bioinformatics #Collaboration #Genetics / genomics #Oncology #Partnership

Partners hope to “chart a new era of drug discovery”

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments.  In this partnership, M2GEN will license its real-world data set (RWD) to Zephyr AI, while Zephyr AI will… Read More

#Cancer Research #News

#Assay development optimisation & technology #Cancer immunotherapy #Cancer research #Immuno-oncology #Immunotherapy #Oncology

The evolution of assays for immuno-oncology research

Listen to this article on the DDW Podcast: By Dr Shailendra Singh, founder and CEO of Cellomatics Biosciences. Cancer is a complex heterogenous multistep disease characterised by uncontrolled cell proliferation combined with a dysregulated immune response. The number of new cases recorded between 2016 and 2018 was 375,400, with 167,142 deaths… Read More

#Cancer Research #Exclusive Content

Tumour microenvironment
#Absci #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer research #Oncology #St John’s Cancer Institute #Tumours

Partners use AI to speed up development of cancer therapies

AI company Absci and St John’s Cancer Institute (SJCI) have entered a partnership to uncover breakthrough cancer therapies.   The companies will use Absci’s Integrated Drug Creation platform, which combines generative AI models and proprietary wet-lab technologies, and SJCI’s cancer biospecimen repository and molecular database to identify new… Read More

#Cancer Research #News

Patient having a mammogram
#Breast cancer #Cancer research #Clinical research #Clinical trials #Oncology #Phase II trial

Breast cancer still top disease area for clinical studies

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, despite a drop in activity, according to analysis from analytics company Phesi.  The company’s global analysis of all clinical trials conducted in 2022 showed that Covid-19 came second.   Three of… Read More

#Cancer Research #News

#Cancer immunotherapy #Cancer research #Immuno-oncology #Immunotherapy #Oncology #Phase III trial

Immunotherapy offers survival extension for brain tumour patients

Listen to this article on the DDW Podcast: Why data from a Phase III clinical trial offers promise for patients with a deadly form of brain cancer. A Phase III clinical trial has produced promising results for a cancer vaccine targeting patients with a new or recurrent glioblastoma.  The study, which… Read More

#Cancer Research #Exclusive Content

Stamp of approval
#AstraZeneca #Cancer #Chemotherapy #Clinical research #MHRA #Oncology

First-line AZ treatment for adults with biliary tract cancer approved 

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to AstraZeneca for Imfinzi (durvalumab) in combination with gemcitabine and cisplatin in Great Britain for use as a first-line treatment of adults with locally advanced, unresectable or metastatic biliary tract cancer (BTC).1 This authorisation by… Read More

#Cancer Research #News

DNA unwinding from histones
#Cancer research #DNA mutations #Epigenetics #Oncology

The ‘dark matter’ behind cancer

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong looks into recent research which may explain why cancers can become more aggressive. Researchers in London and Milan may have discovered why cancers can become more aggressive without relying only on DNA mutations. A lot of research to do… Read More

#Cancer Research #Exclusive Content

Mammography
#Breast cancer #Cancer research #European Commission #Gene mutation #Genetics / genomes #HER2 #Oncology

Drug approved for breast cancer with low levels of HER2 expression

Enhertu has been approved in the EU as the first HER2 directed therapy for patients with HER2 low metastatic breast cancer.  The drug is approved as monotherapy for adult patients who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within six… Read More

#Cancer Research #Editor's Choice #News

#Cancer research #Immune system #Immunotherapy #Oncology #Tumour biology #Tumours

Avoiding detection – the cancer cells evading the body’s natural defence

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong explores recent research looking into why cancer cells are so effective at avoiding the body’s immune system. Scientists may have discovered clues to why cancer cells can avoid the body’s immune system in a study conducted by researchers at… Read More

#Cancer Research #Exclusive Content

Skin cancer cells
#AI / data analytics / healthtech / informatics #Cancer #Cancer research #Cell #Melanoma #Oncology

Study reveals impact of cancer cell size on treatment response

Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.  Scientists at The Institute of Cancer Research, London, combined biochemical profiling technologies with mathematical analyses to reveal how genetic changes lead to differences in the size of… Read More

#Cancer Research #News